Kogen Biotech, a leading company in the in-vitro diagnostics industry, has developed over 1,000 PCR Kits, including the 1st SARS-CoV-2 Real-time PCR Kit in South Korea. Their extensive product portfolio covers emerging diseases, clinical diagnostics, food safety, animal diseases, and pathogens. Kogen Biotech aims to improve public healthcare by cooperating with government authorities, national research institutes, hospitals, and medical centers.